propranolol has been researched along with Angiogranuloma in 10 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Airway tumors are rare in children." | 1.91 | Rare airway tumor in a previously healthy adolescent successfully treated with endoscopic resection and oral propranolol. ( Gipsman, AI; Piccione, J; Treat, JR, 2023) |
| "No recurrence was reported in any of the patients who achieved complete resolution after 3 months of follow-up." | 1.62 | Topical β-blockers for pyogenic granulomas: A promising option for younger patients. ( Al-Refaie, AAA; El-Taweel, AEI; Salem, KHA; Salem, RM, 2021) |
| "Disseminated congenital pyogenic granuloma (DCPG) is an uncommon condition." | 1.51 | Multifocal congenital pyogenic granuloma successfully treated with oral propranolol. ( Al-Khenaizan, S; ALFalah, M; Alfuraih, A; Alharbi, M; Alomair, IA; Cho-Vega, JH; Eber, AE; Nouri, K; Perper, M, 2019) |
| "A retrospective study of all cases of pyogenic granuloma treated with topical propranolol 4% gel between 2014 and 2015 was performed." | 1.51 | Effectiveness of topical propranolol 4% gel in the treatment of pyogenic granuloma in children. ( Hadj-Rabia, S; Harel, A; Kutz, A; Mashiah, J; Slodownik, D; Sprecher, E, 2019) |
| "Pain, permanent scarring, and pigmentation are potential complications of these therapies." | 1.48 | Topical 1% propranolol ointment with occlusion in treatment of pyogenic granulomas: An open-label study in 22 children. ( Balestri, R; Baraldi, C; Neri, I; Patrizi, A; Piraccini, BM, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gipsman, AI | 1 |
| Treat, JR | 1 |
| Piccione, J | 1 |
| Dany, M | 1 |
| Goetze, AC | 1 |
| Sasaya, EMK | 1 |
| Cerci, FB | 1 |
| Tolkachjov, SN | 1 |
| Werner, B | 1 |
| El-Taweel, AEI | 1 |
| Al-Refaie, AAA | 1 |
| Salem, KHA | 1 |
| Salem, RM | 1 |
| Fattore, D | 1 |
| Di Guida, A | 1 |
| Detoraki, A | 1 |
| De Fata Salvatores, G | 1 |
| Gallo, L | 1 |
| Fabbrocini, G | 1 |
| Neri, I | 1 |
| Baraldi, C | 1 |
| Balestri, R | 1 |
| Piraccini, BM | 1 |
| Patrizi, A | 1 |
| Alharbi, M | 1 |
| Eber, AE | 1 |
| Perper, M | 1 |
| ALFalah, M | 1 |
| Al-Khenaizan, S | 1 |
| Alomair, IA | 1 |
| Alfuraih, A | 1 |
| Nouri, K | 1 |
| Cho-Vega, JH | 1 |
| Mashiah, J | 1 |
| Hadj-Rabia, S | 1 |
| Slodownik, D | 1 |
| Harel, A | 1 |
| Sprecher, E | 1 |
| Kutz, A | 1 |
| Lee, N | 1 |
| Isenstein, A | 1 |
| Zedek, D | 1 |
| Morrell, DS | 1 |
| Hochman, M | 1 |
2 reviews available for propranolol and Angiogranuloma
| Article | Year |
|---|---|
Beta-Blockers for Pyogenic Granuloma: A Systematic Review of Case Reports, Case Series, and Clinical Trials
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Betaxolol; Clinical Tr | 2019 |
Management of vascular tumors.
Topics: Adrenergic beta-Antagonists; Child; Granuloma, Pyogenic; Hemangioendothelioma; Hemangioma; Humans; K | 2012 |
8 other studies available for propranolol and Angiogranuloma
| Article | Year |
|---|---|
Rare airway tumor in a previously healthy adolescent successfully treated with endoscopic resection and oral propranolol.
Topics: Adolescent; Adult; Child; Female; Granuloma, Pyogenic; Hemoptysis; Humans; Neoplasms; Propranolol; T | 2023 |
Pyogenic Granuloma of the Lip With Complete Resolution After Topical Propranolol
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Biopsy; Granuloma, Pyogenic; Humans; Li | 2019 |
Topical β-blockers for pyogenic granulomas: A promising option for younger patients.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Granuloma, Pyogenic; Humans; Propranolol; Recu | 2021 |
Successful treatment of eruptive pyogenic granuloma with propranolol.
Topics: Exanthema; Granuloma, Pyogenic; Humans; Propranolol | 2021 |
Topical 1% propranolol ointment with occlusion in treatment of pyogenic granulomas: An open-label study in 22 children.
Topics: Administration, Cutaneous; Child; Child, Preschool; Cicatrix; Female; Granuloma, Pyogenic; Humans; I | 2018 |
Multifocal congenital pyogenic granuloma successfully treated with oral propranolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Granuloma, Pyogenic; Humans; Infant; Male; Propra | 2019 |
Effectiveness of topical propranolol 4% gel in the treatment of pyogenic granuloma in children.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Child; Child, Preschool; Female; Gels; Granu | 2019 |
A case of childhood subcutaneous pyogenic granuloma (lobular capillary hemangioma).
Topics: Diagnosis, Differential; Female; Granuloma, Pyogenic; Humans; Infant; Propranolol; Subcutaneous Tiss | 2012 |